Dyslipidemia and ischemic cardiopathy associated with duration of diabetes mellitus in the oldest old: The Octabaix Study

Journal of the American Geriatrics Society

Volumn 60, Issue 8, 2012, Pages 1594-1596

  Padrõs, Glòria ^a   Ferrer, Assumpta ^b   Formiga, Francesc ^c,d   Almeda, Jesús ^e,f   March, M Antonia ^g   Pujol, Ramõn ^c  

^a Clinical Laboratoy l'Hospitalet Cornellà de Llobregat   (Spain)

^b Primary Healthcare Center   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^e IDIAP ICS   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g Pharmacy University   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE DURATION; DYSLIPIDEMIA; FOOD INTAKE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LETTER; MALNUTRITION;

AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84865126924     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2012.04087.x     Document Type: Letter

References (10)

1. Fox CS, Sullivan L, D'Agostino RB Sr, et al. Framingham Heart Study. The significant effect of diabetes duration on coronary heart disease mortality. The Framingham Heart Study. Diabetes Care 2004; 27: 704-708. (Pubitemid 38280537)
2. Cano JF, Baena-Diez JM, Franch J, et al. Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: A population-based cohort study in southern Europe. Diabetes Care 2010; 33: 2004-2009.
3. Ferrer A, Padrõs G, Formiga F, et al. Diabetes mellitus: Prevalence and impact of morbidities in the oldest old. The Octabaix Study. J Am Geriatr Soc 2012; 60: 462-467.
4. Patel A, MacMahon S, Chalmers J, et al. ADVANCE collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572. (Pubitemid 351831357)
5. Suh DC, Kim CM, Choi IS, et al. Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. J Am Geriatr Soc 2008; 56: 484-492.
6. Rastogi R, Saudek C, Brancati F, et al. Association of diabetes, comorbidities, and A1C with functional disability in older adults. Diabetes Care 2010; 33: 1055-1060.
7. Vischer UM, Bauduceau B, Bourdel-Marchasson I, et al. A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes Metab 2009; 35: 168-177.
8. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl 1): S11-S61.
9. Vijayaraghavan K,. Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Dis 2010; 9: 144.
10. Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010; 87: 385-393.